Moreover, we found that FOXM1 overexpression in tumor tissue was also significantly correlated with the 3-year OS (OR = 2.62, 95% CI = 1.62 to 4.26, P < 0.0001) and 5-year OS (OR = 3.12, 95% CI = 1.56 to 6.28, P = 0.001) of patients with cancer in early stage (Supplementary Figure 2). This evidence concerns the gene FOXM1 and cancer.